Saint Michael's Medical Center
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1867-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.smmcnj.com
Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)
Phase 4
Active, not recruiting
- Conditions
- Human Immunodeficiency Virus
- Interventions
- Drug: Dolutegravir/Lamivudine
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Saint Michael's Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04826562
- Locations
- ๐บ๐ธ
Saint Michael's Medical Center, Newark, New Jersey, United States
Portal-724 MEMS for Medication Adherence Patients Taking HCV Medications
Completed
- Conditions
- Adherence
- Interventions
- Device: Portal-724 MEMs Cap
- First Posted Date
- 2016-08-08
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Saint Michael's Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02858050
- Locations
- ๐บ๐ธ
Saint Michael's Medical Center, Newark, New Jersey, United States
Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study
Phase 4
Completed
- Conditions
- Hepatitis C InfectionHIV Infection
- Interventions
- Drug: Sofosbuvir, Ribavirin, and Stribild
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Saint Michael's Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT02220868
- Locations
- ๐บ๐ธ
Saint Michael's Medical Center, Newark, New Jersey, United States
Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.
- Conditions
- Coronary Disease
- First Posted Date
- 2012-06-01
- Last Posted Date
- 2013-02-22
- Lead Sponsor
- Saint Michael's Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01609569
- Locations
- ๐บ๐ธ
Saint Michael's Medical Center, Newark, New Jersey, United States
Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients
- First Posted Date
- 2008-09-15
- Last Posted Date
- 2011-07-20
- Lead Sponsor
- Saint Michael's Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00752037
- Locations
- ๐บ๐ธ
Saint Michael's Medical Center, Newark, New Jersey, United States
Directly Observed Therapy in High Risk Populations in Newark, NJ
Phase 3
Completed
- Conditions
- Directly Observed TherapyHIV Infections
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2006-02-28
- Lead Sponsor
- Saint Michael's Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00285883
- Locations
- ๐บ๐ธ
Saint Michael's Medical Center, Newark, New Jersey, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath